Protagonist Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	9,859	5,466	2,356	1,323	538	1,636
Market Cap Growth	210.30%	131.99%	78.04%	145.83%	-67.10%	85.52%
Enterprise Value	9,018	4,909	1,948	982.78	304.59	1,315
Last Close Price	152.35	87.34	38.60	22.93	10.91	34.20
PE Ratio	124.82	-	9.13	-	-	-
Forward PE	60.90	59.76	36.33	-	-	-
PS Ratio	34.87	118.78	5.42	22.05	20.25	59.80
PB Ratio	11.40	8.89	3.49	3.93	2.50	5.45
P/TBV Ratio	12.19	9.03	3.72	3.87	2.48	5.28
P/FCF Ratio	75.30	97.46	12.89	-	-	-
P/OCF Ratio	74.95	94.77	12.79	-	-	-
EV/Sales Ratio	31.89	106.67	4.48	16.38	11.46	48.07
EV/EBITDA Ratio	150.17	-	7.68	-	-	-
EV/EBIT Ratio	154.14	-	7.70	-	-	-
EV/FCF Ratio	68.87	87.53	10.66	-	-	-
Debt / Equity Ratio	0.01	0.01	0.02	0	0.01	0.01
Debt / EBITDA Ratio	0.15	-	0.04	-	-	-
Debt / FCF Ratio	0.07	0.18	0.06	-	-	-
Net Debt / Equity Ratio	-0.92	-0.91	-0.60	-1.01	-1.08	-1.07
Net Debt / EBITDA Ratio	-12.91	3.55	-1.61	3.67	1.79	2.57
Net Debt / FCF Ratio	-5.92	-9.93	-2.23	4.81	2.15	2.95
Asset Turnover	0.36	0.07	0.79	0.20	0.09	0.08
Quick Ratio	21.50	12.49	12.32	16.53	7.61	7.53
Current Ratio	21.71	12.71	12.48	16.71	7.80	7.74
Return on Equity (ROE)	-5.40%	-20.18%	54.39%	-28.59%	-49.41%	-43.32%
Return on Assets (ROA)	7.08%	-22.53%	45.17%	-30.91%	-44.11%	-37.44%
Return on Invested Capital (ROIC)	16.87%	-97.97%	189.05%	-	-	-
Return on Capital Employed (ROCE)	7.93%	-23.96%	48.91%	-33.84%	-50.49%	-42.81%
Earnings Yield	0.84%	-	10.96%	-	-	-
FCF Yield	1.33%	1.03%	7.76%	-	-	-
Buyback Yield / Dilution	-4.05%	2.31%	-14.65%	-15.74%	-5.87%	-34.67%
Total Shareholder Return	-4.05%	2.31%	-14.65%	-15.74%	-5.87%	-34.67%

SEC Filings: 10-K · 10-Q